HomepageEarnings Events Newsdesk 22 hours ago Jazz Pharmaceuticals PLC (JAZZ) Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) FY 2026 Other Release Omega Healthcare Investors, Inc (OHI) Q4 2025 Earnings Call » « American International Group Inc (AIG) AIG Completes Its Planned CEO Transition Plan Newsdesk:
